Viewing Study NCT01159769


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2025-12-25 @ 8:21 PM
Study NCT ID: NCT01159769
Status: COMPLETED
Last Update Posted: 2012-04-03
First Post: 2010-07-08
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
Sponsor: Alcon Research
Organization: